Načítá se...

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline

OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Behav
Hlavní autoři: Eliassen, Carl F., Reinvang, Ivar, Selnes, Per, Grambaite, Ramune, Fladby, Tormod, Hessen, Erik
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/
https://ncbi.nlm.nih.gov/pubmed/28948074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!